Interstitial lung disease is not rare in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies.

BMC Pulm Med · 2022 · PMC8744320 · PMID 35000598

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significancep values > 0.05actually significant

Regarding MAAs, the frequency of ANA, SSA and Ro-52 antibody were somewhat higher in the ILD group than patients without ILD, but the differences did not reach statistical significance (all p values > 0.05).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.